FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jul. 24, 2018--
MEDNAX, Inc. (NYSE:MD), will host an investor conference call and
webcast on Thursday, August 2, 2018 at 10:00 a.m. ET, to discuss results
from operations for the quarter and the six months ended June 30, 2018.
A detailed press release will be issued the morning of August 2, 2018
before the securities markets open.
The investor conference call will be webcast and can be accessed at
MEDNAX’s website, www.mednax.com/investors.
MEDNAX, Inc. is a national health solutions partner based in Sunrise,
Fla. comprised of the nation's leading providers of physician services.
Physicians and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, clinical research and telemedicine to enhance patient
outcomes and provide high-quality, cost-effective care. The Company was
founded in 1979, and today, through its affiliated professional
corporations, MEDNAX provides services through a network of
approximately 4,100 physicians in all 50 states and Puerto Rico. In
addition to its national physician network, MEDNAX provides services to
healthcare facilities and physicians in over 40 states through two
complementary businesses, consisting of a revenue cycle management
company and a consulting services company. Additional information is
available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could
cause actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and Exchange
View source version on businesswire.com: https://www.businesswire.com/news/home/20180724005177/en/
Source: MEDNAX, Inc.
Charles Lynch, 954-384-0175, Ext. 5692
President, Strategy and Investor Relations